Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade

Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.

The 10 Most Serious Problems Taxpayers Have With The IRS

In her new report to Congress, National Taxpayer Advocate Erin Collins outlined the 10 biggest challenges taxpayers now face when dealing with the tax agency.

Michael Johnson’s Grand Slam Track league owes $40.68M, per filings

Michael Johnson’s Grand Slam Track league owes $40.68 million, according to new bankruptcy filings.

'Never thought a meet would not pay:' Grand Slam Track bankruptcy takes a toll on struggling runners

His name wasn't splashed across any of the headlines when Grand Slam Track — the running league that was supposed to infuse ...

Michael Johnson’s Grand Slam Track league owes $40.68m, according to new filings

New documents reveal the stark financial shortfall of the start-up track league - including the cash owed and salary drawn by ...